+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chemotherapy Induced Peripheral Neuropathy Drug"

From
Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Chemotherapy Induced Peripheral Neuropathy (CIPN) is a type of peripheral neuropathy caused by certain chemotherapy drugs. It is a common side effect of chemotherapy, and can cause pain, numbness, tingling, and burning sensations in the hands and feet. CIPN drugs are used to treat the symptoms of CIPN, and can include anticonvulsants, antidepressants, and opioids. These drugs are used to reduce pain, improve nerve function, and improve quality of life. CIPN drugs are part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy. The CNS drug market is a rapidly growing market, driven by the increasing prevalence of neurological disorders and the development of new treatments. Some companies in the CIPN drug market include Pfizer, Novartis, Merck, and Johnson & Johnson. These companies are involved in the development and marketing of CIPN drugs, as well as other CNS drugs. Show Less Read more